Copoly.ai

A Consultancy Built by The Team That Ships Its Own Products

The Impact
Copoly is one of the few firms that builds and operates its own AI-powered biomarker platform (OncoSage) and sovereign enterprise AI platform (OfficeSage). The consulting practice is staffed by the same team — bringing PhD-level scientific expertise (Experimental Medicine, Biochemistry & Bioinformatics) and applied AI / Data Science leadership (MSc Data Science) into every engagement. When we advise on AI in life sciences, healthcare, or government, we are drawing on real, deployed experience — not slideware.

A Rigorous, Collaborative Consulting Approach

How We Work
image 01

Discover & Strategize

We start by deeply understanding the scientific, operational, and compliance context of your problem.

image 02

Build & Implement

We design and build the AI, bioinformatics, or hybrid solution required — not generic toolkits, but production systems.

image 03

Measure & Optimize

We measure impact, refine, and ensure your team owns the outcome.

Previous
Next
  • AI Consulting

    From AI readiness assessments and adoption roadmaps to custom model development and implementation — we help organisations navigate AI strategically and confidently.

Real Problems. Real Outcomes.

Client Highlights
We work on problems that matter — across government, biopharma, and high-stakes research environments. Here are a few examples of the work we’ve delivered.
  • Semiconductor

    Worked with a semiconductor company to develop an AI-driven yield optimization pipeline, reducing analysis cycles and informing process decisions in production.

  • Biopharma

    Built a custom multi-omics pipeline for a biopharma partner, accelerating biomarker analysis from weeks to days and supporting downstream regulatory submissions.

  • Government

    Designed and presented a sovereign AI productivity solution to Canadian federal departments, including a high-security environment.

Bring Us Your Hardest Problem

Work With Us
Whether you need a strategic AI roadmap, a production bioinformatics pipeline, or a sovereign AI deployment, we’d like to hear about your challenge.